Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

36.9%

45 terminated/withdrawn out of 122 trials

Success Rate

61.5%

-25.0% vs industry average

Late-Stage Pipeline

16%

19 trials in Phase 3/4

Results Transparency

39%

28 of 72 completed trials have results

Key Signals

28 with results35 terminated10 withdrawn

Enrollment Performance

Analytics

N/A
34(33.0%)
Phase 2
31(30.1%)
Phase 1
19(18.4%)
Phase 3
10(9.7%)
Phase 4
9(8.7%)
103Total
N/A(34)
Phase 2(31)
Phase 1(19)
Phase 3(10)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (122)

Showing 20 of 122 trials
NCT00059930Phase 1Completed

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Role: collaborator

NCT00176644Phase 2Terminated

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Role: lead

NCT00118131Phase 2Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Role: lead

NCT00161213Phase 2Completed

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Role: lead

NCT00786682Phase 2Terminated

Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer

Role: lead

NCT00765765Phase 1Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Role: lead

NCT00468130Not ApplicableCompleted

Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children

Role: lead

NCT00176592Phase 4Completed

Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI

Role: lead

NCT00161252Withdrawn

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Role: lead

NCT00900120Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

Role: lead

NCT00695201Phase 1Completed

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Role: collaborator

NCT00467818Not ApplicableCompleted

Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders

Role: lead

NCT00467753Not ApplicableCompleted

Oxcarbazepine Versus Placebo in Childhood Autism

Role: lead

NCT01533376Phase 1Terminated

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Role: collaborator

NCT00201227Not ApplicableCompleted

Trial to Enhance Adherence to Multiple Guidelines

Role: lead

NCT00728845Phase 1Terminated

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Role: lead

NCT00143819Phase 2Terminated

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

Role: lead

NCT00422695Completed

Pain and Sensory Changes Assessment in HIV+ Patients

Role: lead

NCT00176488Phase 2Terminated

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Role: lead

NCT00163657Phase 4Completed

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

Role: collaborator